Opexa Therapeutics, Inc. (OPXA) Widens Q1 Loss to 10c/Share

Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q1 EPS of ($0.10), versus ($0.06) reported last year.

For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Forgent Power Solutions jumps as Bernstein sees massive earnings upside
• DBS cuts Sea target as Shopee spending weighs on profit growth